Department of Public Health Management and Policy, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0203, USA.
Med Care. 2010 Jan;48(1):79-84. doi: 10.1097/mlr.0b013e3181b72395.
Although investigations using Medicare claims files are ubiquitous in the health services research literature, Medicaid claims files are used less frequently. Nonetheless, Medicaid is the major payer for healthcare among low-income persons.
To assess the added value of Medicaid claim files for identifying comorbid conditions and cancer treatments in a dually eligible sample.
Data were obtained from linked statewide tumor registries from 2 contiguous Midwestern states (Michigan and Ohio), Medicare and Medicaid enrollment files, and Medicare and Medicaid claims files. We estimated the prevalence of Charlson Comorbidity Index conditions by counting the number of patients with these conditions in the Medicare claims files alone. We then estimate the expected percent increase in the prevalence of comorbid conditions (along with the 95% confidence interval) that could be obtained by using both Medicare and Medicaid claim files. We followed a similar procedure to identify treatments provided to dually eligible patients.
Medicaid claims added very few individuals with comorbid conditions over those identified through Medicare claim files. The increase in the prevalence of comorbid conditions was between 0% and 2.5%. Likewise, Medicaid claims identified few individuals with cancer treatments who were not already identified through Medicare claim files, although variations were noted between the 2 states.
This study suggests that the incremental value of Medicaid inpatient, outpatient, and carrier claims is relatively small over what can be obtained from Medicare claims data.
尽管医疗保险索赔文件在卫生服务研究文献中无处不在,但医疗补助索赔文件的使用频率较低。然而,医疗补助是低收入人群医疗保健的主要支付者。
评估在双重合格样本中使用医疗补助索赔文件识别合并症和癌症治疗的附加价值。
数据来自 2 个相邻中西部州(密歇根州和俄亥俄州)的全州肿瘤登记处、医疗保险和医疗补助登记处以及医疗保险和医疗补助索赔文件。我们通过仅在医疗保险索赔文件中计算患有这些疾病的患者人数来估计 Charlson 合并症指数疾病的患病率。然后,我们估计通过使用医疗保险和医疗补助索赔文件可以获得的合并症患病率的预期百分比增加(以及 95%置信区间)。我们遵循类似的程序来识别双重合格患者接受的治疗。
与通过医疗保险索赔文件识别的患者相比,医疗补助索赔仅增加了极少数患有合并症的患者。合并症患病率的增加在 0%到 2.5%之间。同样,医疗补助索赔仅确定了少数未通过医疗保险索赔文件识别的癌症治疗患者,尽管在这两个州之间存在差异。
本研究表明,与从医疗保险索赔数据中获得的信息相比,医疗补助住院、门诊和承运人索赔的增量价值相对较小。